Literature DB >> 12615751

Ramipril use in Canada: HOPE or HYPE?

Louise Pilote1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12615751      PMCID： PMC149251     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group.

Authors:  I Giatras; J Lau; A S Levey
Journal:  Ann Intern Med       Date:  1997-09-01       Impact factor: 25.391

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.

Authors:  B Neal; S MacMahon; N Chapman
Journal:  Lancet       Date:  2000-12-09       Impact factor: 79.321

4.  The striking effect of the Heart Outcomes Prevention Evaluation (HOPE) on ramipril prescribing in Ontario.

Authors:  Karen Tu; Muhammad M Mamdani; Robert M Jacka; Natalie J Forde; Deanna M Rothwell; Jack V Tu
Journal:  CMAJ       Date:  2003-03-04       Impact factor: 8.262

5.  Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

Authors:  R Garg; S Yusuf
Journal:  JAMA       Date:  1995-05-10       Impact factor: 56.272

6.  Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group.

Authors: 
Journal:  Circulation       Date:  1998-06-09       Impact factor: 29.690
  6 in total
  4 in total

1.  More than just hype.

Authors:  Wally Shishkov
Journal:  CMAJ       Date:  2003-06-24       Impact factor: 8.262

2.  More than just hype.

Authors:  Ronald J Sigal
Journal:  CMAJ       Date:  2003-06-24       Impact factor: 8.262

3.  More than just hype.

Authors:  David Fitchett
Journal:  CMAJ       Date:  2003-06-24       Impact factor: 8.262

4.  More than just hype.

Authors:  Salim Yusuf; Gilles Dagenais
Journal:  CMAJ       Date:  2003-06-24       Impact factor: 8.262
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.